These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2568886)

  • 1. Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients.
    Nanbara S; Arinaga S; Akiyoshi T
    Cancer Immunol Immunother; 1989; 29(4):237-41. PubMed ID: 2568886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the generation of OK-432 activated killer cells after a single dose of mitomycin C in cancer patients.
    Arinaga S; Akiyoshi T; Tsuji H
    Int J Immunopharmacol; 1988; 10(1):47-51. PubMed ID: 2966774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C.
    Arinaga S; Karimine N; Adachi M; Inoue H; Nanbara S; Asoh T; Ueo H; Akiyoshi T
    Cancer Immunol Immunother; 1993 Sep; 37(4):220-6. PubMed ID: 8348560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.
    Dianzani U; Zarcone D; Pistoia V; Grossi CE; Pileri A; Massaia M; Ferrarini M
    Eur J Immunol; 1989 Jun; 19(6):1037-44. PubMed ID: 2502419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory correlates of chemoimmunotherapy with low-dose recombinant interleukin-2 and mitomycin C in patients with advanced carcinoma.
    Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Abe R; Watanabe D; Asoh T; Ueo H; Akiyoshi T
    Cancer Invest; 1994; 12(6):588-96. PubMed ID: 7994593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma.
    Koyama S
    J Cancer Res Clin Oncol; 1997; 123(9):478-84. PubMed ID: 9341896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC; Hargrove ME; Yun YS
    J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of lymphokine-activated killer cell activity by low-dose recombinant interleukin-2 and tumor cells.
    Yamamoto S; Hoon DS; Chandler P; Schmid I; Irie RF
    Cell Immunol; 1990 Jul; 128(2):516-27. PubMed ID: 1972659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: expression of the NKH-1 and CD3 antigens.
    Ramsdell FJ; Gray JD; Golub SH
    Cell Immunol; 1988 Jun; 114(1):209-21. PubMed ID: 2967111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS; Hargrove ME; Ting CC
    Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of pokeweed mitogen on the proliferation and the cytotoxicity of lymphokine-activated killer cells.
    Kimoto Y; Tanaka T; Fujiwara A; Fujita M; Taguchi T
    Jpn J Cancer Res; 1992 Jun; 83(6):631-7. PubMed ID: 1379578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
    Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
    Rabinowich H; Sedlmayr P; Herberman RB; Whiteside TL
    Cell Immunol; 1991 Jul; 135(2):454-70. PubMed ID: 1709827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.